USA flag logo/image

An Official Website of the United States Government

Company Information:

Company Name:
ARADIGM CORPORATION
Address:
3929 POINT EDEN WAY
HAYWARD, CA 94545-
Phone:
(510) 265-8834
URL:
EIN:
194313308
DUNS:
792998783
Number of Employees:
11
Woman-Owned?:
No
Minority-Owned?:
No
HUBZone-Owned?:
No

Commercialization:

Has been acquired/merged with?:
N/A
Has had Spin-off?:
N/A
Has Had IPO?:
N/A
Year of IPO:
N/A
Has Patents?:
N/A
Number of Patents:
N/A
Total Sales to Date $:
$ 0.00
Total Investment to Date $
$ 0.00
POC Title:
N/A
POC Name:
N/A
POC Phone:
N/A
POC Email:
N/A
Narrative:
N/A

Award Totals:

Program/Phase Award Amount ($) Number of Awards
SBIR Phase I $940,493.00 5
SBIR Phase II $750,000.00 1

Award List:

PULMONARY GENE TRANSFER DELIVERY SYSTEMS

Award Year / Program / Phase:
1997 / SBIR / Phase I
Award Amount:
$99,750.00
Agency:
HHS
Principal Investigator:
Gonda, igor
Abstract:
DESCRIPTION: (Adapted from the Applicant's Abstract). Inhaled gene products are desirable for chronic respiratory diseases with high morbidity and mortality, e.g. cystic fibrosis, emphysema, asthma, lung cancer, and tuberculosis. Aerosolization of DNA (plasmids) using conventional flow-through… More

PULMONARY GENE TRANSFER DELIVERY SYSTEMS

Award Year / Program / Phase:
1998 / SBIR / Phase II
Award Amount:
$750,000.00
Agency:
HHS
Principal Investigator:
Gonda, igor
Abstract:
DESCRIPTION: (Adapted from the Applicant's Abstract). Inhaled gene products are desirable for chronic respiratory diseases with high morbidity and mortality, e.g. cystic fibrosis, emphysema, asthma, lung cancer, and tuberculosis. Aerosolization of DNA (plasmids) using conventional flow-through… More

Developing Human-Compatible Needleless Delivery Systems for Administering Bioscavengers

Award Year / Program / Phase:
2003 / SBIR / Phase I
Award Amount:
$70,000.00
Agency / Branch:
DOD / ARMY
Principal Investigator:
Deepa Deshpande, Senior Scientist
Abstract:
The goals of this proposal are: 1) to identify a BChE formulation that will deliver the target systemic dose via the lungs; 2) to ensure that the integrity of the BChE protein is unaffected by the aerosolization process; and 3) to measure the efficiency ofdelivering BChE to the systemic circulation… More

Pulmonary delivery of nicotine using the AERx System

Award Year / Program / Phase:
2005 / SBIR / Phase I
Award Amount:
$153,151.00
Agency:
HHS
Principal Investigator:
Abstract:
DESCRIPTION (provided by applicant): Each year more Americans die from smoking-related diseases than from alcohol, AIDS, drug abuse, car accidents, fire, suicide and murder-combined. Smoking costs the United States approximately $97.2 billion each year in healthcare costs and lost productivity.… More

Evaluation of a new class of molecules for treating MRSA infective endocarditis

Award Year / Program / Phase:
2013 / SBIR / Phase I
Award Amount:
$277,768.00
Agency:
HHS
Principal Investigator:
James D. Blanchard – 510-265-8871
Abstract:
DESCRIPTION (provided by applicant): Lung infections by Mycobacterium avium and Mycobacterium abscessus are increasing in incidence. Diseases caused by both Mycobacteria are common in patients with chronic lung conditions, such as cystic fibrosis (CF), non-CF bronchiectasis and emphysema. In… More

Amplified Attention Training (AAT) for the Treatment of Hemispatial Nelgect

Award Year / Program / Phase:
2013 / SBIR / Phase I
Award Amount:
$339,824.00
Agency:
HHS
Principal Investigator:
Igor Gonda – 510-265-8850
Abstract:
DESCRIPTION (provided by applicant): Although recurrent microaspiration of refluxed gastric fluid ( GER with microaspiration ) is suspected in the onset and course of many diseases of the lungs and airways, the lack of a non-invasive, direct test for its occurrence has hampered research on its… More